Recombinant Human Hyaluronidase in Treating Lymphedema in Patients With Cancer

NCT01928030 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Lymphedema
Malignant Neoplasm

Interventions

BIOLOGICAL: recombinant human hyaluronidase

Sponsor

Stanford University

Collaborators

[object Object]